4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000045
Chief Scientific Officer acquired 9,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Jewell Christopher M · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-10 | Exercise or conversion : show line 1 in the form | +9,000 | $3.23 | $29,070 | 62,490 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-10 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −9,000 | 67,432 | D |
Loading xslF345X05/wk-form4_1736802540.xml…